DBVT Q2 2020 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$538M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+6.3% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$48M-1321.2% margin

Net Income

-$48M-1335.3% margin

EPS (Diluted)

$-4.40

QoQ Revenue Growth

-23.5%

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$41M

Stock-Based Comp.

-$6M

Balance Sheet

Total Assets

$337M

Total Liabilities

$85M

Stockholders' Equity

$252M

Cash & Equivalents

$254M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$3M	+6.3%
Gross Profit	$4M	$3M	+6.3%
Operating Income	-$48M	-$45M	-5.7%
Net Income	-$48M	-$45M	-6.2%